Alison Armour
Company: CURADH Pharmaceuticals
Job title: Founder and CMO
Seminars:
Fireside: Paving the Path for Novel Radiopharmaceutical Targets or Following Bonified ADC Targets: Advantages & Pitfalls 12:10 pm
Leveraging established ADC Targets for radiopharmaceuticals for well characterized mechanism of action such as NECTIN-4 Identifying and pursuing untapped biological targets to revolutionize radiopharmaceuticals such as failed ADC targets Commercial considerations to balance risks and hurdlesRead more
day: Conference Day One
Chair’s Closing Remarks 4:50 pm
day: Conference Day One
Panel Discussion: Investigating Attributes of a Prime Radiopharmaceutical Target to Match the Properties of a Radioactive Drug 9:00 am
Considering receptor density, expression levels and radiosensitive tissues Analyzing alpha vs beta emitter target requirements for optimal strategy Assessing stromal targeting such as FAP or internalized targetsRead more
day: Conference Day One
Chair’s Opening Remarks 8:50 am
day: Conference Day One